Are Robust Financials Driving The Recent Rally In Imeik Technology Development Co.,Ltd.'s (SZSE:300896) Stock?

Simply Wall StMar 14 02:43 ET

Is Imeik Technology Development's premium of 13 times for controlling the leading aesthetic medical brand in South Korea too high?| K Commentary

① Imeik Technology Development holds a 13 times premium stake in South Korea's REGEN Biotech, which possesses two core products, AestheFill and PowerFill; ② If Imeik Technology Development wants to reclaim exclusive agency rights for AestheFill in China from JiangSu WuZhong Pharmaceutical Development, certain costs will inevitably need to be incurred; ③ The competition in the medical beauty regeneration sector is intensifying, and recently two hydroxyapatite products have been approved.

cls.cnMar 13 07:57 ET

Research Reports Digging for Gold | Sinolink: Maintains Imeik Technology Development 'Buy' rating, plans to acquire South Korea's REGEN, accelerating international expansion.

Sinolink Research Reports pointed out that Imeik Technology Development (300896.SZ) plans to acquire REGEN from South Korea, accelerating its international layout. The target company has two mature products, with the first factory having sufficient production capacity and the second factory about to be put into operation. Since its products were launched, their safety and effectiveness have been fully recognized by the market, and multiple international academic articles have been published. After this acquisition, the company is expected to leverage the target company's market channels and brand influence in South Korea and globally, rapidly enhancing its visibility and market share in the international medical beauty market, breaking dependency on the domestic market and achieving a global layout. At the same time, the core product is 可.

Gelonghui FinanceMar 11 03:21 ET

Express News | Imeik Technology Says Imeik International Plans to Buy 85% Stake in Regen Biotech for $190 Mln

ReutersMar 10 07:06 ET

Shanghai Securities: The GMV growth of Douyin and Taotian Cosmetics is impressive. Pay attention to leading companies in the medical beauty and Cosmetic industries.

The long-term penetration rate of medical beauty is expected to continue to increase, and leading domestic brands in the Cosmetic Industry are likely to maintain their lead through various advantages such as brand, channels, products, and Operation.

Zhitong FinanceFeb 17 00:50 ET

Imeik Technology Development Co.,Ltd.'s (SZSE:300896) Earnings Are Not Doing Enough For Some Investors

Simply Wall StFeb 15 19:02 ET